Autologous tumor-reactive T cells therapy (Geekgene)

N/A

Report date: 2026/02/03 20:00:14

Base Information

Drug NameAutologous tumor-reactive T cells therapy (Geekgene)
Drug Alias NameGK-02
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsUpdating
Therapy Area/IndicationsAscites
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Geekgene Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Geekgene Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsAscites
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A